Latest Articles
- Research ArticleInflammatory Biomarkers in Newly Diagnosed Patients With Parkinson Disease and Related Neurodegenerative DisordersCamilla Christina Pedersen, Anastasia Ushakova, Ragnhild Eide Skogseth, et al.May 31, 2023
- Research ArticleInternational Delphi Consensus on the Management of AQP4-IgG+ NMOSDRecommendations for Eculizumab, Inebilizumab, and SatralizumabFriedemann Paul, Romain Marignier, Jacqueline Palace, et al.May 31, 2023
- Clinical/Scientific NoteMRI Features and Their Association With Outcomes in Children With Anti-NMDA Receptor EncephalitisGrace Gombolay, J. Nicholas Brenton, Jennifer H. Yang, et al.May 26, 2023
- Clinical/Scientific NoteImmunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic ThrombocytopeniaThomas Geeraerts, Céline Guilbeau-Frugier, Cédric Garcia, et al.May 26, 2023
- Research ArticleMesiotemporal Volumetry, Cortical Thickness, and Neuropsychological Deficits in the Long-term Course of Limbic EncephalitisAntonia Harms, Tobias Bauer, Juri-Alexander Witt, et al.May 25, 2023
- Research ArticleLate-Onset Anti-GABAB Receptor EncephalitisClinical Characteristics and Outcomes Differing From Early-Onset PatientsTangna Sun, Daidi Zhao, Gejuan Zhang, et al.May 25, 2023
- Clinical/Scientific NoteAnti-LGI1 Encephalitis With Co-occurring IgLON5 AntibodiesClinical Features and Human Leukocyte Antigen HaplotypesPierre Schiff, Sergio Muñiz-Castrillo, Le Duy Do, et al.May 22, 2023
- Research ArticleMultiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for PregnancyKerstin Hellwig, Marianne Tokic, Sandra Thiel, et al.May 22, 2023
- Clinical/Scientific NoteAnti–GABA-A Receptor Antibody-Mediated Epilepsia Partialis Continua After Treatment With AlemtuzumabA Case ReportDominica Ratuszny, Thomas Skripuletz, Thomas Stüber, et al.May 18, 2023
Pages
Advertisement
Dr. Nicole Sur and Dr. Mausaminben Hathidara